INSIGHTS ON CLINICAL TRIAL DESIGN
-
Top Approach To High Volume Enrollment In Clinical Research
Integrating technology with personalized support can ethically, efficiently, and transparently scale patient recruitment, ultimately improving trial outcomes and advancing translational research.
-
Navigating The Confluence Of AI And Community-Based Trials
Artificial intelligence (AI) is transforming clinical trials, enhancing efficiency, participation, and diversity, particularly within hybrid trial models.
-
Expanding Clinical Research In East Africa With Digital Innovation
Africa carries 25% of the world’s disease burden but hosts only 1% of clinical trials. Discover technology-driven strategies that close this gap and transform research access in underserved regions.
-
How Pharmaceutical Companies Can Effectively Engage With PAOs
Experts explain the role of Patient Advocacy Organizations (PAOs), tips for pharmaceutical companies and PAOs to forge strong relationships, and techniques to integrate patient perspectives.
-
FDA Draft Guidance On Diversity Action Plan Requirements10/24/2024
Explore new drafted guidance under FDORA that substantiates the mandate of a Diversity Action Plan (DAP) for late-stage trial protocol submissions.
-
Accelerating Clinical Trials Through Streamlined Confidential Disclosure Agreements2/9/2026
In this presentation, Dr. Christine Senn addresses the persistent challenge of study startup delays by focusing on a primary legal hurdle: the Confidential Disclosure Agreement (CDA).
-
5 Strategies For Designing Successful Complex Rare Disease Trials3/31/2026
Rare disease trials demand inventive design. Uncover creative strategies that help sponsors overcome tiny populations, complex endpoints, and operational hurdles to advance meaningful breakthroughs.
-
Multi-Regional Clinical Trials: The Latest Guidance From FDA3/12/2025
Conducting multi-regional clinical trials (MRCTs) is essential for accelerating oncology drug development and ensuring broader patient access. However, differences across regions can impact findings.
-
Can Patient Liaison Services Transform Clinical Research Access?9/25/2025
Patients often face invisible hurdles in research. Watch how Patient Liaison services can change the journey for participants, sites, and sponsors, making trials easier to join and stay in.
CLINICAL TRIAL DESIGN SOLUTIONS
-
With its agile, user-centric approach, Elosity empowers sponsors, sites, and operational teams to manage clinical programs on their terms while meeting the demands of modern clinical research.
-
Automate protocol design, database builds, and validation to cut study setup from months to days — enabling faster analytics, earlier insights, and trial simulation.
-
With three clinical pharmacology units, access to 145,000+ hepatic/renal patients, and 100+ completed studies, we’re your partner for NDA-enabling trials.
-
Explore this suite of multichannel, patient-centered solutions that are powering rapid clinical trial education, engagement, and enrollment.
-
Enable consistent protocol execution with standardized workflows for training, monitoring, documentation, inventory, and drug accountability.